Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle

American Journal of Physiology - Cell Physiology

Volumn 292, Issue 5, 2007, Pages

  Alfieri, Christina M ^a   Evans Anderson, Heather J ^a   Yutzey, Katherine E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Gene regulation; Insulin like growth factor I; Nuclear factor of activated T cells c3; Skeletal muscle

Indexed keywords

CALCINEURIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC3; TRANSCRIPTION FACTOR NFATC4; UNCLASSIFIED DRUG; MESSENGER RNA; NFATC3 PROTEIN, MOUSE; NFATC4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; EMBRYO; EMBRYO DEVELOPMENT; EXON; GENE EXPRESSION; GENE SEQUENCE; MOUSE; MOUSE STRAIN; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE; ANIMAL; CONSENSUS SEQUENCE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUSCLE DEVELOPMENT; MUTATION; MYOBLAST; PRENATAL DEVELOPMENT; PROTEIN BINDING; SIGNAL TRANSDUCTION; TIME;

MURINAE;

ANIMALS; BASE SEQUENCE; CALCINEURIN; CONSENSUS SEQUENCE; EMBRYO; EXONS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INSULIN-LIKE GROWTH FACTOR I; MICE; MOLECULAR SEQUENCE DATA; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUTATION; MYOBLASTS, SKELETAL; NFATC TRANSCRIPTION FACTORS; NIH 3T3 CELLS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 34250621799     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00506.2006     Document Type: Article

References (56)

1. Abbott KL, Friday BB, Thaloor D, Murphy TJ, Pavlath GK. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol Biol Cell 9: 2905-2916, 1998.
2. Anderson JP, Dodou E, Heidt AB, DeVal SJ, Jaehnig EJ, Greene SB, Olson EN, Black BL. HRC is a direct transcriptional target of MEF2 during cardiac, skeletal and arterial smooth muscle development in vivo. Mol Cell Biol 24: 3757-3768, 2004.
3. Andres V, Cervera M, Mahdavi V. Determination of the binding site for MEF1 expressed in muscle and brain reveals tissue-specific sequence constraints. J Biol Chem 270: 23246-23249, 1995.
4. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82, 1993.
5. Bartke A. Role of the growth hormone/Insulin-like growth factor system in mammalian aging. Endocrinology 146: 3718-3723, 2005.
6. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275: 1930-1934, 1997.
7. Bushdid PB, Osinska H, Waclaw RR, Molkentin JD, Yutzey KE. NFATc3 and NFATc4 are required for cardiac development and mitochondrial function. Circ Res 92: 1305-1313, 2003.
8. Butler AA, LeRoith D. Tissue-specific versus generalized gene targeting of the igf1 and igfr genes and their roles in insulin-like growth factor physiology. Endocrinology 142: 1685-1688, 2001.
9. Chia DJ, Ono M, Woelfle J, Schlesinger-Massart M, Jiang H, Rotwein P. Characterization of distinct Stat5 binding sites that mediate growth hormone stimulated IGF-I gene transcription. J Biol Chem 281: 3190-3197, 2006.
10. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Zhu W, Bassel-Duby R, Williams RS. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 12: 2499-2509, 1998.
11. De la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR, Mak TW. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182-186, 1998.
12. Delling U, Tureckova J, De Windt LJ, Rotwein P, Molkentin JD. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol 20: 6600-6611, 2000.
13. Florini JR, Ewton DZ, Coolican SA. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17: 481-517, 1996.
14. Frazer KA, Pachter LS, Poliakov A, Rubin EM, Dubchak I. VISTA: computational tools for comparative genomics. Nucleic Acids Res 32: W273-W279, 2004.
15. Friday BB, Horsley V, Pavlath GK. Calcineurin activity is required for the initiation of skeletal muscle differentiation. J Cell Biol 149: 657-665, 2000.
16. Goldspink G. Mechanical signals, IGF-1 gene splicing, and muscle adaptation. Physiology 20: 232-238, 2005.
17. Hall LJ, Kajimoto Y, Bichell D, Kim SW, James PL, Counts D, Nixon LJ, Tobin G, Rotwein P. Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter. DNA Cell Biol 11: 301-313, 1992.
18. Ho SN, Thomas DJ, Timmerman LA, Li X, Francke U, Crabtree GR. NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity. J Biol Chem 270: 19898-19907, 1995.
19. Kegley KM, Gephart J, Warren GL, Pavlath GK. Altered primary myogenesis in NFATC3-/- mice leads to decreased muscle size in the adult. Dev Biol 232: 115-126, 2001.
20. Ko LJ, Engel JD. DNA-binding specificities of the GATA transcription factor family. Mol Cell Biol 13: 4011-4022, 1993.
21. Lange AW, Molkentin JD, Yutzey KE. DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice. Dev Biol 266: 346-360, 2004.
22. Lincoln J, Alfieri CM, Yutzey KE. BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev Biol 292: 290-302, 2006.
23. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (igfr1). Cell 75: 59-72, 1993.
24. Mayor C, Brudno M, Schwartz JR, Poliakov A, Rubin EM, Frazer KA, Pachter LS, Dubchak I. VISTA: visualizing global DNA sequence alignments of arbitrary length. Bioinformatics 16: 1046-1047, 2000.
25. McCall GE, Allen DL, Haddad F, Baldwin KM. Transcriptional regulation of IGF-I expression in skeletal muscle. Am J Physiol Cell Physiol 285: C831-C839, 2003.
26. McLellan AS, Kealey T, Langlands K. An E-box in the exon 1 promoter regulates insulin-like growth factor-1 expression in differentiating muscle cells. Am J Physiol Cell Physiol 291: C300-C307, 2006.
27. Merika M, Orkin SH. DNA-binding specificity of GATA family transcription factors. Mol Cell Biol 13: 3999-4010, 1993.
28. Mittanck DW, Kim SW, Rotwein P. Essential promoter elements are located within the 5′ untranslated region of the human insulin-like growth factor-I exon I. Mol Cell Endocrinol 126: 153-163, 1997.
29. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998.
30. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB, Weintraub H, Baltimore D. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58: 537-544, 1989.
31. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27: 195-200, 2001.
32. Musaro A, McCullagh KJA, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal muscle hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400: 581-585, 1999.
33. Naya FJ, Mercer B, Shelton J, Richardson JA, Williams RS, Olson EN. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem 275: 4545-4548, 2000.
34. Nolten LA, Steenbergh PH, Sussenbach JS. Hepatocyte nuclear factor 1 alpha activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites. Mol Endocrinol 9: 1488-1499, 1995.
35. Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, Neilson JR, Liberatore CM, Yutzey KE, Crabtree GR, Tsika RW, Molkentin JD. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem 279: 26192-26200, 2004.
36. Plageman TF Jr, Yutzey KE. Differential expression and function of Tbx5 and Tbx20 in cardiac development. J Biol Chem 279: 19026-19034, 2004.
37. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA. IGF-I is required for normal embryonic growth in mice. Genes Dev 7: 2609-2617, 1993.
38. Ranger AM, Grusby MJ, Gravallese EM, de la Brousse FC, Hoey T, Mickanin C, Baldwin HS, Glimcher LH. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186-190, 1998.
39. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15: 707-747, 1997.
40. Rotwein P, Bichell DP, Kikuchi K. Multifactorial regulation of IGF-I gene expression. Mol Reprod Dev 35: 358-363, 1993.
41. Salma N, Xiao E, Mueller E, Imbalzano AN. Temporal recruitment of transcription factors and SWI/SNF chromatin remodeling enzymes during adipogenic induction of the PPARγ nuclear hormone receptor. Mol Cell Biol 24: 4651-4663, 2004.
42. Schulz RA, Yutzey KE. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol 266: 1-16, 2004.
43. Schulze PC, Fang J, Kassik KA, Gannon J, Cupesi M, MacGillivray C, Lee RT, Rosenthal N. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricle dysfunction. Circ Res 97: 418-426, 2005.
44. Searcy RD, Vincent EB, Liberatore CM, Yutzey KE. A GATA-dependent nkx-2.5 regulatory element activates early cardiac gene expression in transgenic mice. Development 125: 4461-4470, 1998.
45. 2+-dependent calcineurin signalling pathway. Nature 400: 576-581, 1999.
46. Shavlakadze T, Winn N, Rosenthal N, Grounds MD. Reconciling data from transgenic mice that overexpress IGF-1 specifically in skeletal muscle. Growth Hormone IGF Res 15: 4-18, 2005.
47. Shemer J, Adamo ML, Roberts CT, LeRoith D. Tissue-specific transcription start site usage in the leader exons of the rat insulin-like growth factor-I gene: evidence for differential regulation in the developing kidney. Endocrinology 131: 2793-2799, 1992.
48. Shen T, Liu Y, Cseresnyes Z, Hawkins A, Randall WR, Schneider MF. Activity- and calcineurin-independent nuclear shuttling of NFATc1, but not NFATc3, in adult skeletal muscle fibers. Mol Biol Cell 17: 1570-1582, 2006.
49. Thomas MJ, Umayahara Y, Shu H, Centrella M, Rotwein P, McCarthy TL. Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts. J Biol Chem 271: 21835-21841, 1996.
50. Umayahara Y, Billiard J, Ji C, Centrella M, McCarthy TL, Rotwein P. CCAAT/Enhancer-binding protein δ is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts. J Biol Chem 274: 10609-10617, 1999.
51. Wang L, Wang X, Adamo ML. Two putative GATA motifs in the proximal exon 1 promoter of the rat insulin-like growth factor I gene regulate basal promoter activity. Endocrinology 141: 1118-1126, 2000.
52. Wang X, Yang Y, Adamo ML. Characterization of the rat insulin-like growth factor I gene promoters and identification of a minimal exon 2 promoter. Endocrinology 138: 1528-1536, 1997.
53. Wilkins BJ, de Windt LJ, Bueno OF, Braz JC, Glascock BJ, Kimball TF, Molkentin JD. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol Cell Biol 22: 7603-7613, 2002.
54. Wu H, Rothermel BA, Kanatous S, Rosenberg P, Naya FJ, Shelton JM, Hutcheson KA, DiMaio JM, Olson EN, Bassel-Duby R, Williams RS. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J 20: 6414-6423, 2001.
55. Yang J, Rothermel BA, Vega RB, Frey N, McKinsey TA, Olson EN, Bassel-Duby R, Williams RS. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 87: e61-e68, 2000.
56. Yoshiko Y, Hirao K, Maeda N. Differentiation in C2C12 myoblasts depends on the expression of endogenous IGFs and not serum depletion. Am J Physiol Cell Physiol 283: C1278-C1286, 2002.